Holdings
Profund Vp Pharmaceuticals
As of Jun 30, 2026, Profund Vp Pharmaceuticals reported 65 positions worth US$11.2M. Largest: Definium Therapeutics, Inc., MBX Biosciences, Inc. and Alumis Inc. What it bought and sold, with each filing.
Holdings
- Positions
- 65
- Value as reported
- US$11.2M
- Holdings as of
- Jun 30, 2026
- Last filed
- Aug 28, 2026
| Company | Shares | Value as reported | % of portfolio | Change | As of |
|---|---|---|---|---|---|
| Definium Therapeutics, Inc. NASDAQ:DFTX | 7,334 | US$345K | 3.0% | −2,719 | Jun 30, 2026 |
| MBX Biosciences, Inc. NASDAQ:MBX | 5,500 | US$304K | 2.6% | −869 | Jun 30, 2026 |
| Alumis Inc. NASDAQ:ALMS | 8,497 | US$239K | 2.1% | +1,387 | Jun 30, 2026 |
| AtaiBeckley Inc. NASDAQ:ATAI | 45,092 | US$238K | 2.1% | New | Jun 30, 2026 |
| Trevi Therapeutics, Inc. NASDAQ:TRVI | 12,720 | US$237K | 2.1% | −2,966 | Jun 30, 2026 |
| Enliven Therapeutics, Inc. NASDAQ:ELVN | 4,607 | US$234K | 2.0% | −1,494 | Jun 30, 2026 |
| Amylyx Pharmaceuticals, Inc. NASDAQ:AMLX | 12,663 | US$227K | 2.0% | +119 | Jun 30, 2026 |
| Veradermics, Incorporated NYSE:MANE | 1,833 | US$225K | 2.0% | New | Jun 30, 2026 |
| Ligand Pharmaceuticals Incorporated NASDAQ:LGND | 687 | US$217K | 1.9% | −160 | Jun 30, 2026 |
| Nuvation Bio Inc. NYSE:NUVB | 37,216 | US$211K | 1.8% | −3,587 | Jun 30, 2026 |
| Edgewise Therapeutics, Inc. NASDAQ:EWTX | 5,178 | US$210K | 1.8% | −865 | Jun 30, 2026 |
| Nektar Therapeutics NASDAQ:NKTR | 3,002 | US$210K | 1.8% | +448 | Jun 30, 2026 |
| Liquidia Corporation NASDAQ:LQDA | 2,612 | US$208K | 1.8% | −2,245 | Jun 30, 2026 |
| Maze Therapeutics, Inc. NASDAQ:MAZE | 6,930 | US$207K | 1.8% | +3,217 | Jun 30, 2026 |
| Harrow, Inc. NASDAQ:HROW | 4,748 | US$202K | 1.8% | −322 | Jun 30, 2026 |
| EyePoint, Inc. NASDAQ:EYPT | 13,824 | US$198K | 1.7% | +1,271 | Jun 30, 2026 |
| Amneal Pharmaceuticals, Inc. NASDAQ:AMRX | 11,126 | US$193K | 1.7% | −3,609 | Jun 30, 2026 |
| Ocular Therapeutix, Inc. NASDAQ:OCUL | 19,502 | US$192K | 1.7% | −213 | Jun 30, 2026 |
| Corcept Therapeutics Incorporated NASDAQ:CORT | 2,182 | US$190K | 1.6% | −3,369 | Jun 30, 2026 |
| Crinetics Pharmaceuticals, Inc. NASDAQ:CRNX | 4,965 | US$186K | 1.6% | −100 | Jun 30, 2026 |
| Pacira BioSciences, Inc. NASDAQ:PCRX | 7,278 | US$185K | 1.6% | −926 | Jun 30, 2026 |
| Merck & Company, Inc. NYSE:MRK | 1,431 | US$184K | 1.6% | −181 | Jun 30, 2026 |
| Indivior Pharmaceuticals, Inc. NASDAQ:INDV | 4,475 | US$184K | 1.6% | −1,230 | Jun 30, 2026 |
| Elanco Animal Health Incorporated NYSE:ELAN | 7,453 | US$183K | 1.6% | −534 | Jun 30, 2026 |
| Johnson & Johnson NYSE:JNJ | 715 | US$182K | 1.6% | −56 | Jun 30, 2026 |
| Eli Lilly and Company NYSE:LLY | 150 | US$180K | 1.6% | −37 | Jun 30, 2026 |
| Jazz Pharmaceuticals plc NASDAQ:JAZZ | 742 | US$179K | 1.6% | −268 | Jun 30, 2026 |
| Collegium Pharmaceutical, Inc. NASDAQ:COLL | 4,898 | US$177K | 1.5% | −360 | Jun 30, 2026 |
| Bristol-Myers Squibb Company NYSE:BMY | 3,066 | US$177K | 1.5% | −57 | Jun 30, 2026 |
| Supernus Pharmaceuticals, Inc. NASDAQ:SUPN | 3,780 | US$176K | 1.5% | +261 | Jun 30, 2026 |
| Royalty Pharma plc NASDAQ:RPRX | 3,127 | US$175K | 1.5% | −884 | Jun 30, 2026 |
| Tarsus Pharmaceuticals, Inc. NASDAQ:TARS | 2,782 | US$175K | 1.5% | +102 | Jun 30, 2026 |
| Wave Life Sciences Ltd. NASDAQ:WVE | 30,115 | US$175K | 1.5% | +16,813 | Jun 30, 2026 |
| Harmony Biosciences Holdings, Inc. NASDAQ:HRMY | 4,804 | US$175K | 1.5% | −1,701 | Jun 30, 2026 |
| ANI Pharmaceuticals, Inc. NASDAQ:ANIP | 2,084 | US$173K | 1.5% | −371 | Jun 30, 2026 |
| Organon & Co. NYSE:OGN | 12,739 | US$172K | 1.5% | −16,525 | Jun 30, 2026 |
| Viatris Inc. NASDAQ:VTRS | 10,808 | US$172K | 1.5% | −2,598 | Jun 30, 2026 |
| Esperion Therapeutics, Inc. NASDAQ:ESPR | 54,283 | US$172K | 1.5% | −15,347 | Jun 30, 2026 |
| Axsome Therapeutics, Inc. NASDAQ:AXSM | 692 | US$169K | 1.5% | −482 | Jun 30, 2026 |
| Innoviva, Inc. NASDAQ:INVA | 7,411 | US$168K | 1.5% | −943 | Jun 30, 2026 |
| BioAge Labs, Inc. NASDAQ:BIOA | 6,835 | US$168K | 1.5% | +142 | Jun 30, 2026 |
| Prestige Consumer Healthcare Inc. NYSE:PBH | 3,469 | US$164K | 1.4% | +579 | Jun 30, 2026 |
| Rapport Therapeutics, Inc. NASDAQ:RAPP | 3,855 | US$161K | 1.4% | −412 | Jun 30, 2026 |
| Pfizer, Inc. NYSE:PFE | 6,658 | US$160K | 1.4% | −202 | Jun 30, 2026 |
| Omeros Corporation NASDAQ:OMER | 16,711 | US$159K | 1.4% | +1,012 | Jun 30, 2026 |
| Perrigo Company plc NYSE:PRGO | 15,260 | US$159K | 1.4% | −3,832 | Jun 30, 2026 |
| Xeris Biopharma Holdings, Inc. NASDAQ:XERS | 19,640 | US$156K | 1.4% | −11,312 | Jun 30, 2026 |
| Zoetis Inc. NYSE:ZTS | 2,097 | US$151K | 1.3% | +534 | Jun 30, 2026 |
| Eton Pharmaceuticals, Inc. NASDAQ:ETON | 4,026 | US$146K | 1.3% | New | Jun 30, 2026 |
| Phibro Animal Health Corporation NASDAQ:PAHC | 4,568 | US$143K | 1.2% | +1,407 | Jun 30, 2026 |
| Amphastar Pharmaceuticals, Inc. NASDAQ:AMPH | 6,925 | US$140K | 1.2% | −298 | Jun 30, 2026 |
| Arvinas, Inc. NASDAQ:ARVN | 16,762 | US$139K | 1.2% | +5,275 | Jun 30, 2026 |
| Zevra Therapeutics, Inc. NASDAQ:ZVRA | 9,630 | US$138K | 1.2% | −677 | Jun 30, 2026 |
| Alto Neuroscience, Inc. NYSE:ANRO | 4,959 | US$131K | 1.1% | +2,634 | Jun 30, 2026 |
| Phathom Pharmaceuticals, Inc. NASDAQ:PHAT | 10,944 | US$119K | 1.0% | −1,711 | Jun 30, 2026 |
| Relmada Therapeutics, Inc. NASDAQ:RLMD | 17,078 | US$118K | 1.0% | New | Jun 30, 2026 |
| CorMedix Inc. NASDAQ:CRMD | 14,334 | US$113K | 0.98% | −3,251 | Jun 30, 2026 |
| Septerna, Inc. NASDAQ:SEPN | 3,303 | US$111K | 0.96% | −778 | Jun 30, 2026 |
| Theravance Biopharma, Inc. NASDAQ:TBPH | 6,286 | US$107K | 0.93% | −2,242 | Jun 30, 2026 |
| Aclaris Therapeutics, Inc. NASDAQ:ACRS | 18,874 | US$99,843 | 0.87% | New | Jun 30, 2026 |
| LB Pharmaceuticals Inc NASDAQ:LBRX | 2,742 | US$88,992 | 0.77% | −88 | Jun 30, 2026 |
| Aquestive Therapeutics, Inc. NASDAQ:AQST | 20,535 | US$85,426 | 0.74% | +1,490 | Jun 30, 2026 |
| Fulcrum Therapeutics, Inc. NASDAQ:FULC | 21,055 | US$77,061 | 0.67% | +9,389 | Jun 30, 2026 |
| Lexicon Pharmaceuticals, Inc. NASDAQ:LXRX | 29,252 | US$70,205 | 0.61% | New | Jun 30, 2026 |
| Evolus, Inc. Common Stock NASDAQ:EOLS | 8,464 | US$58,740 | 0.51% | New | Jun 30, 2026 |